Loading...
Powered By
13 items
2025-05-27
Tri Chemical Laboratories Inc. has signed a memorandum of understanding with Hefei ADChem Semi-Tech. Co. Ltd. ("ADChem") for mutual cooperation in exploring the feasibility of joint ventures in the production and sale of semiconductor materials in China.
2025-04-18
Tri Chemical Laboratories Inc. has been moving forward with the construction of a new plant in Minami-Alps City, Yamanashi Prefecture, as announced in the "Notice Regarding Commencement of Studies for the Construction of New Plant" dated December 15, 2022. Now, the company announced that the completion ceremony for the new plant was successfully held on April 18, 2025. Overview of the New Plant: Name; Minami-Alps Plant. Address 1020-1 Shimoimai, Minami-Alps City, Yamanashi Prefecture. Site area; Approx. 30,136 m². Total floor area; Approx. 5,690 m². Scheduled start of operations; First half of 2025. Products to be manufactured; New etching materials, CVD materials, etc. for next-generation semiconductors. Investment amount Approx. JPY 12.0 billion.
2025-03-14
Tri Chemical Laboratories Inc., Annual General Meeting, Apr 24, 2025.
2025-03-14
Tri Chemical Laboratories Inc. provided consolidated earnings guidance for the six months ending July 31, 2025. For the six months, the company expects net sales of JPY 12,300 million, operating profit of JPY 3,050 million, profit attributable to owners of parent of JPY 2,550 million or JPY 78.47 basic earnings per share. For the year ending January 31, 2026, the company expects net sales of JPY 26,000 million, operating profit of JPY 6,050 million, profit attributable to owners of parent of JPY 5,000 million or JPY 153.86 basic earnings per share.
2025-03-14
Tri Chemical Laboratories Inc. announced dividend for the year ended January 31, 2025 is JPY 35.00 per share against JPY 30.00 per share a year ago. Scheduled date to commence dividend payments is April 25, 2025.
2025-03-14
Tri Chemical Laboratories Inc. provided dividend guidance for the year ending January 31, 2026. For the year, the company expects to pay dividend of JPY 35.00 against JPY 35.00 a year ago.
2025-03-14
Tri Chemical Laboratories Inc., 2025 Earnings Call, Mar 17, 2025
2025-01-17
Tri Chemical Laboratories Inc. announced that they will report Q1, 2026 results on May 30, 2025
2024-09-28
Tri Chemical Laboratories Inc. announced that they will report Q3, 2025 results on Nov 29, 2024
2024-09-04
Tri Chemical Laboratories Inc., H1 2025 Earnings Call, Sep 02, 2024
2024-09-04
Tri Chemical Laboratories Inc. provided consolidated earnings guidance for the full fiscal year ending January 31, 2025. For the period, the company expects net sales to be JPY 17,000 million, operating profit to be JPY 3,900 million and profit attributable to owners of parent to be JPY 4,260 million or JPY 131.09 per basic share.
2024-09-03
Tri Chemical Laboratories Inc., Q2 2025 Earnings Call, Aug 30, 2024
2024-08-30
Tri Chemical Laboratories Inc. expected to report Q3 2025 results on November 29, 2024. This event was calculated by S&P Global (Created on August 30, 2024).
2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|
Total Revenues | 22,201 | 18,905 | 16,136 | 13,598 | 11,292 | 11,246 | 11,879 |
Pretax Income Excl.Unusual Items | 7,155 | 6,582 | 5,212 | 4,050 | 3,050 | 3,300 | 3,036 |
Total Assets | 38,804 | 36,944 | 38,215 | 33,529 | 33,615 | 31,864 | 31,603 |
Total Liabilities | 7,487 | 5,357 | 8,417 | 4,757 | 6,118 | 4,295 | 4,667 |
Cash & Cash Equivalents | 7,991 | 9,439 | 10,953 | 9,530 | 11,154 | 10,497 | 11,387 |
Total Common Equity | 31,317 | 31,587 | 29,798 | 28,772 | 27,497 | 27,569 | 26,936 |
Book Value Per Share (BVPS) | 963.71 | 972 | 916.94 | 885.38 | 846.14 | 848.36 | 828.88 |
Net Change in Cash | -3,163 | -1,058 | -435 | -2,713 | -1,234 | -640 | 461 |
Capital Expenditure | -3,417 | -3,069 | -2,065 | -2,091 | -1,961 | -1,739 | -1,765 |
As of May 30, 2025, Tri Chemical Laboratories published financial results for the first quarter of 2025, having revenues of 6.57B yen and net income of 1.21B yen, reflecting a significant 100.7% surge in revenue, in addition to a substantial 48.7% rise in EPS compared to the corresponding quarter of the previous year. A positive sign is that for the 5th consecutive quarter, the company has demonstrated an increase in its income line compared to the corresponding quarter of the previous year, indicating the company's stability and potential for growth in the future.
In addition, the EBITDA margin improved from 30.6% in the corresponding quarter last year to 32.3%. Negatively, there is another notable figure. The quarterly free cash flow was -0.11B yen, which is a decrease of -1.7B yen over the same time last year. Even though the company's cash flow did not improve, the management returned a substantial amount of 1.09B yen to shareholders, of which 1.09B yen was paid as a dividend and 135K yen as a repurchase of Common Stock. The dividend yield for this stock is approximately 1.3%, and it trades at 19.6x times current year's earnings, which is higher than the sector average (P/E 15x).